Literature DB >> 18310106

Approaches to dimensionality reduction in proteomic biomarker studies.

Melanie Hilario1, Alexandros Kalousis.   

Abstract

Mass-spectra based proteomic profiles have received widespread attention as potential tools for biomarker discovery and early disease diagnosis. A major data-analytical problem involved is the extremely high dimensionality (i.e. number of features or variables) of proteomic data, in particular when the sample size is small. This article reviews dimensionality reduction methods that have been used in proteomic biomarker studies. It then focuses on the problem of selecting the most appropriate method for a specific task or dataset, and proposes method combination as a potential alternative to single-method selection. Finally, it points out the potential of novel dimension reduction techniques, in particular those that incorporate domain knowledge through the use of informative priors or causal inference.

Mesh:

Substances:

Year:  2008        PMID: 18310106     DOI: 10.1093/bib/bbn005

Source DB:  PubMed          Journal:  Brief Bioinform        ISSN: 1467-5463            Impact factor:   11.622


  32 in total

Review 1.  Finding biomarkers is getting easier.

Authors:  Brian Patrick Bradley
Journal:  Ecotoxicology       Date:  2012-03-13       Impact factor: 2.823

2.  A data-mining approach to biomarker identification from protein profiles using discrete stationary wavelet transform.

Authors:  Hussain Montazery-Kordy; Mohammad Hossein Miran-Baygi; Mohammad Hassan Moradi
Journal:  J Zhejiang Univ Sci B       Date:  2008-11       Impact factor: 3.066

Review 3.  Image analysis tools and emerging algorithms for expression proteomics.

Authors:  Andrew W Dowsey; Jane A English; Frederique Lisacek; Jeffrey S Morris; Guang-Zhong Yang; Michael J Dunn
Journal:  Proteomics       Date:  2010-12       Impact factor: 3.984

4.  A critical assessment of feature selection methods for biomarker discovery in clinical proteomics.

Authors:  Christin Christin; Huub C J Hoefsloot; Age K Smilde; B Hoekman; Frank Suits; Rainer Bischoff; Peter Horvatovich
Journal:  Mol Cell Proteomics       Date:  2012-10-31       Impact factor: 5.911

5.  Screening and validation for plasma biomarkers of nephrotoxicity based on metabolomics in male rats.

Authors:  Yubo Li; Haoyue Deng; Liang Ju; Xiuxiu Zhang; Zhenzhu Zhang; Zhen Yang; Lei Wang; Zhiguo Hou; Yanjun Zhang
Journal:  Toxicol Res (Camb)       Date:  2015-11-05       Impact factor: 3.524

6.  A comparison of methods for classifying clinical samples based on proteomics data: a case study for statistical and machine learning approaches.

Authors:  Dayle L Sampson; Tony J Parker; Zee Upton; Cameron P Hurst
Journal:  PLoS One       Date:  2011-09-28       Impact factor: 3.240

7.  Challenges and opportunities for discovery of disease biomarkers using urine proteomics.

Authors:  Alex Kentsis
Journal:  Pediatr Int       Date:  2011-02       Impact factor: 1.524

8.  Chemometrics of differentially expressed proteins from colorectal cancer patients.

Authors:  Lay-Chin Yeoh; Saravanan Dharmaraj; Boon-Hui Gooi; Manjit Singh; Lay-Harn Gam
Journal:  World J Gastroenterol       Date:  2011-04-28       Impact factor: 5.742

9.  Multivariate meta-analysis of proteomics data from human prostate and colon tumours.

Authors:  Lina Hultin Rosenberg; Bo Franzén; Gert Auer; Janne Lehtiö; Jenny Forshed
Journal:  BMC Bioinformatics       Date:  2010-09-17       Impact factor: 3.169

10.  Systems medicine: the future of medical genomics and healthcare.

Authors:  Charles Auffray; Zhu Chen; Leroy Hood
Journal:  Genome Med       Date:  2009-01-20       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.